Foot Science International has been in the business of facilitating healthy and active lifestyles for over 40 years. The company specializes in designing and manufacturing customisable foot orthoses, aimed at preventing injuries and falls, providing greater comfort and performance, and treating individuals suffering from lower limb and back pain.
The flagship product, FORMTHOTICS, has been a champion brand of the company for four decades, prescribed by medical practitioners, distributed in over 35 countries, and worn by millions. The edge of this product lies in its utilization of CNC milling technology for thermoplastic foam, extensive medical research, and a focus on biomechanics and neuromotor function.
Additionally, its EXPRESS range offers ready-fit medical insoles that support and improve the natural posture of feet, providing a prefabricated, heat-compression molded EVA device based on the proven Formthotics shape.
The company's story dates back to the 1970s in New Zealand, when Dr. Charlie Baycroft and David Boyd co-invented Formthotics, with a shared vision of ensuring people's mobility and activity. Since its inception in 1978, Foot Science International has remained dedicated to developing and improving products that contribute to keeping people active and mobile.
Despite the absence of specific information about recent investments or headquarters, Foot Science International's extensive experience and commitment to its core purpose make it a compelling prospect for potential investors in the Health and Wellness, Manufacturing, and Pharmaceutical industries.
There is no investment information